Knowledge Distillery

Filter the news according their assigned tags.
| Interventional study with open label/non-randomised methodology  

Evaluation of the effects of therapeutic-dose low-molecular-weight heparin vs institutional standard prophylactic or intermediate-dose heparins for…

more...

COVID-19 TREATMENT In this report, the authors describe outcomes in a cohort of patients hospitalized for severe Covid-19 who were treated with…

more...
| Expert opinion  

The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning

 

more...
| Interventional study with open label/non-randomised methodology  

The objective of this study was to determine whether convalescent plasma would improve outcomes for critically ill adults with COVID-19.

more...

COVID-19 TREATMENT In this nice narrative review just published in JAMA, the authors summarize current evidence regarding major proposed treatments,…

more...
| Cross-sectional case-control studies  

Stroke acute management and outcomes during the COVID-19 outbreak: A cohort study from the Madrid stroke network

 

more...
| Case series/case reports  

The authors of this study aimed to characterise myofiber structure in the diaphragm of critically ill patients with COVID-19.

more...
| Observational study: prospective longitudinal cohort  

In this study, recently published in Neurology Neuroimmunology & Neuroinflammation, the authors conducted a survey on the risk of COVID-19 in patients…

more...
| Observational study: prospective longitudinal cohort  

In this paper recently published in Neurology, the authors aimed to determine whether neurological manifestations are common in hospitalised COVID-19…

more...
| Miscellaneous  

SARS-CoV-2 has currently precipitated the COVID-19 global health crisis.

more...
| Miscellaneous  

Most human monoclonal antibodies (mAbs) neutralizing SARS-CoV-2 recognize the spike (S) protein receptor-binding domain and block virus interactions…

more...
| Miscellaneous  

The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding domain (RBD) targeted by most neutralizing antibodies (Abs) in…

more...